All Stories

  1. ¿Cómo prepararnos para una futura pandemia?
  2. The Effectiveness of Generic Piperacillin/Tazobactam in Managing Gram-Negative Bacillary Bacteremia in Adult Patients at a Tertiary Care Hospital
  3. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study
  4. Financiación pública de los sistemas de Ciencia e Innovación en Latinoamérica: Una herramienta esencial para mejorar la prevención y la atención en salud
  5. Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus
  6. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram‐Negative Bacilli Bacteremia: A Randomized Double‐Blind Clinical Study
  7. Challenges and opportunities in the face of Mpox in Latin America
  8. Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis
  9. Mortality Caused by Candida auris Bloodstream Infections in Comparison with Other Candida Species, a Multicentre Retrospective Cohort
  10. Interventions to Improve Antibiotic Use in Hospitals with Different Levels of Complexity in Colombia: Findings from a Before-and-After Study and Suggestions for the Future
  11. Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
  12. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?
  13. Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors
  14. Molecular and Clinical Data of Antimicrobial Resistance in Microorganisms Producing Bacteremia in a Multicentric Cohort of Patients with Cancer in a Latin American Country
  15. Adenovirus Respiratory Infections Post Pandemic in Colombia
  16. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?
  17. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
  18. Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia
  19. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
  20. The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database
  21. Multinational Prospective Cohort Study of Mortality Risk Factors in 198 ICUs of 12 Latin American Countries over 24 Years: The Effects of Healthcare-Associated Infections
  22. Association of medical tests use with care continuity in primary care service: evidence from the Department of Veterans Affairs
  23. Further implications on the global real-world vaccine effectiveness against SARS-CoV-2
  24. The environment also molds microbes in our respiratory airways that are important for our health
  25. Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America
  26. Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population
  27. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
  28. An Operations Approach for Reducing Glycemic Variability: Evidence from a Primary Care Setting
  29. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts
  30. Strengthening a Study of Diabetes Progression After Statin Use—Reply
  31. The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
  32. Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing
  33. Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole
  34. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial
  35. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistantCandida glabrata
  36. Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
  37. Long-term consequences of the misuse of ivermectin data
  38. Association of Statin Therapy Initiation With Diabetes Progression
  39. Enhancing Regulatory Decision Making for Postmarket Drug Safety
  40. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia
  41. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
  42. Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19
  43. Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis
  44. Manifestaciones radiológicas de la melioidosis pulmonar. Serie de casos
  45. SECCION I. Antecedentes de infección por SARS-CoV-2/COVID-19
  46. Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
  47. Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia
  48. Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America
  49. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: a cohort nationwide study
  50. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1–5
  51. Guía de práctica clínica para la tamización de pacientes con riesgo de colonización por Enterobacterales productores de carbapenemasas y el manejo de infecciones causadas por estas bacterias
  52. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort study
  53. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
  54. Experience of clinical screening for COVID-19 among patients undergoing elective orthopedic surgeries: an alternative proposal
  55. Real-World Use of Generic Meropenem: Results of an Observational Study
  56. Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
  57. Burden and magnitude of risk in HIV/AIDS in the Colombian health system: a real-world data approach
  58. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: A cohort nation-wide study
  59. <p>Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery</p>
  60. Real-World Effectiveness of Meropenem: Results of an Observational Study in 84 Colombian Patients
  61. Citoquinas pro y anti-inflamatorias en la infección por SARS-CoV-2, en población de Colombia
  62. Case Report: Gestational Melioidosis through Perinatal Transmission
  63. A One Health Perspective to Recognize Fusarium as Important in Clinical Practice
  64. Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019
  65. A One Health Perspective to Recognize Fusarium and Neocosmospora as Important in Clinical Practice
  66. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible
  67. Maintaining Continuity in Service: An Empirical Examination of Primary Care Physicians
  68. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case‐control study
  69. Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  70. 1596-P: Evaluating Reports of Pancreatic Malignancy and Liraglutide: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
  71. Toward to establish selection criteria for rapid serological tests for COVID-19
  72. Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR – is it a reinfection?
  73. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)
  74. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
  75. Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department
  76. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study
  77. Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
  78. Persistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia
  79. QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care
  80. Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances
  81. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  82. Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia
  83. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module
  84. Risk factors associated with methicillin-resistant Staphylococcus aureus skin and soft tissue infections in hospitalized patients in Colombia
  85. Statin use and medically attended acute respiratory illness among influenza vaccine recipients
  86. Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia
  87. Clinical practice guidelines: An Opportunity to provide health care with excellence and the new Colombian Guidelines for the diagnosis and management of Skin and Soft tissue infections (SSTIs)
  88. Case Series Study of Melioidosis, Colombia
  89. Risk of invasive fungal infections during hospital construction
  90. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure
  91. Abstract 3368: Prevalence and significance of drug-drug interactions among patients with lung cancer
  92. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study
  93. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia
  94. The cost of hospital care for HIV patients in Colombia: an insurer’s perspective
  95. Melioidosis en Colombia, descripción de un caso clínico y consideraciones epidemiológicas
  96. First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient
  97. Antifungal stewardship: consensus on the diagnosis, treatment, and prevention of Candida spp. disease is a fundamental step in the road map to achieve it
  98. Colombian consensus on the diagnosis, treatment, and prevention of Candida Spp. disease in children and adults*,+
  99. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America
  100. Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN
  101. Paracoccidioidomycosis simulating Crohn’s disease
  102. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient
  103. Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study
  104. Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.
  105. Impact of total body weight on acute kidney injury in patients with gram-negative bacteremia
  106. Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas
  107. Polypharmacy and patterns of prescription medication use among cancer survivors
  108. First report of sporadic cases of Candida auris in Colombia
  109. Burden of Fungal Infections in Colombia
  110. What has been researched about MDR- Candida auris ? A bibliometric analysis on the ‘new kid on the block’ in hospital-associated infections
  111. Erratum for Arias et al., “A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries”
  112. Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score–Matched Cohorts
  113. Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis
  114. Usefulness of thick blood smears in the diagnosis of disseminated histoplasmosis
  115. Practical Recommendations for Preoperative Skin Antisepsis
  116. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study
  117. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents
  118. A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries
  119. Association of Statin Use With Risk of Back Disorder Diagnoses
  120. Tigeciclina en infecciones de piel y tejidos blandos complicadas.
  121. First Colombian consensus on congenital Chagas and clinical approach for women of child-bearing age diagnosed with Chagas
  122. Tigeciclina en infecciones intraabdominales complicadas
  123. Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
  124. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I–III Breast Cancer Patients Treated in a Safety-Net Healthcare System
  125. Impact of total body weight on 30-day mortality in patients with gram-negative bacteremia
  126. Lingual tuberculosis in an HIV/AIDS patient
  127. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia
  128. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia
  129. Low–health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications
  130. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
  131. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex
  132. Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study
  133. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line–associated bloodstream infection rates
  134. Consenso colombiano para la estratificación, diagnóstico, tratamiento y prevención de la infección por citomegalovirus en pacientes adultos con trasplante renal
  135. Impact of an Analgesia-Based Sedation Protocol on Mechanically Ventilated Patients in a Medical Intensive Care Unit
  136. Saksenaea erythrospora infection after medical tourism for esthetic breast augmentation surgery
  137. Virus de hepatitis B y C. Retos en su tratamiento
  138. Pérdida de seguimiento y factores asociados en pacientes inscritos en el programa de HIV/sida del Hospital Universitario San Ignacio, Colombia, 2012-2013
  139. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
  140. Abstract C59: Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system
  141. Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano
  142. Challenges with Diagnosing and Managing Sepsis in Older Adults
  143. Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
  144. Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
  145. Risk Factors Associated With Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection in Colombia
  146. Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad
  147. Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian Adults
  148. Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogotá, Colombia
  149. Exposure to High-Risk Medications is Associated With Worse Outcomes in Older Veterans With Chronic Pain
  150. Frecuencia de colonización de staphylococcus aureus meticilino - resistente, de enterobacterias y de candida spp. en estetoscopios y teléfonos móviles en una unidad de cuidados intensivos neonatal
  151. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications
  152. Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
  153. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus
  154. Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study
  155. Multicenter Study of Skin and Soft Tissue Infections Complicated in Hospitalized Patients 2009–2014 in Colombia
  156. Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
  157. Costo-efectividad de linezolid comparado con vancomicina en el manejo de la neumonía asociada a ventilación mecánica en Colombia
  158. Surgical site infection rates in 4 cities in Colombia: Findings of the International Nosocomial Infection Control Consortium (INICC)
  159. Azithromycin for Elderly Patients With Pneumonia—Reply
  160. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistantStaphylococcus aureusbacteraemia
  161. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
  162. Gram-negative infections in pediatric and neonatal intensive care units of Latin America
  163. Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru
  164. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
  165. Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
  166. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas
  167. Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá
  168. Diseminación de Klebsiella pneumoniae productoras de KPC-3 en hospitales de Bogotá durante un periodo de tres años
  169. 155Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013
  170. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia
  171. Efecto del tratamiento antibiótico inicial adecuado sobre la mortalidad en pacientes en estado crítico con bacteriemia por Pseudomonas aeruginosa
  172. Molecular epidemiology and characterization of virulence genes of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Colombia
  173. Resistant Gram-negative infections in the outpatient setting in Latin America
  174. Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010
  175. The Quality of Quality Measures: HEDIS® Quality Measures for Medication Management in the Elderly and Outcomes Associated with New Exposure
  176. Emergencia de fenotipos resistentes a cefalosporinas de tercera generación en Enterobacteriaceae causantes de infección del tracto urinario de inicio comunitario en hospitales de Colombia
  177. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles
  178. Predicting out of intensive care unit cardiopulmonary arrest or death using electronic medical record data
  179. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  180. Consenso colombiano de neumonía nosocomial 2013
  181. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents
  182. Utilidad clínica de la detección antigénica de galactomanano en el diagnóstico de aspergilosis invasora en un hospital universitario de tercer nivel en Bogotá (Colombia) 2010–2012
  183. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia
  184. Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection
  185. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings
  186. Findings of the International Nosocomial Infection Control Consortium (INICC), Part II: Impact of a Multidimensional Strategy to Reduce Ventilator-Associated Pneumonia in Neonatal Intensive Care Units in 10 Developing Countries
  187. Findings of the International Nosocomial Infection Control Consortium (INICC), Part I: Effectiveness of a Multidimensional Infection Control Approach on Catheter-Associated Urinary Tract Infection Rates in Pediatric Intensive Care Units of 6 Developing...
  188. Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  189. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
  190. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima
  191. Effects of Oral Bisphosphonate Therapy on Serum Calcium in Elderly Veterans With Poor Kidney Function
  192. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  193. Ranolazine for the treatment of refractory angina in a veterans population
  194. Uso prudente de antimicrobianos basado en el Plan Obligatorio de Salud
  195. The emergence of multidrug-resistant Acinetobacter baumannii in Colombia: a time-series analysis, 2001-2007
  196. Diagnóstico de micosis oportunistas en pacientes con VIH/sida: un estudio de casos en Colombia
  197. Consenso de uso de antimicrobianos en pacientes críticamente enfermos con falla renal o en riesgo de padecerla
  198. Bacteriemia por Staphylococcus aureus resistente a la meticilina en la unidad de cuidados intensivos: revisión de los estudios de pronóstico
  199. Detección de hipotiroidismo en un programa de atención de VIH/SIDA en un hospital de Bogotá, Colombia
  200. Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries
  201. Guías de práctica clínica para la prevención de infecciones intrahospitalarias asociadas al uso de dispositivos médicos
  202. La prevención de las infecciones asociadas a la atención en salud: un reto en el mejoramiento de la seguridad del paciente
  203. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America
  204. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America
  205. Resistencia bacteriana, transmisión cruzada y control de la infección asociada a la atención en salud
  206. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
  207. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia
  208. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  209. Differences in DeterminingIn VitroTigecycline Susceptibility According to the Agar Medium Used
  210. Central line associated bloodstream infection rates in 166 intensive care units of 54 cities in 23 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  211. Changes in macrophage membrane properties during early Leishmania amazonensis infection differ from those observed during established infection and are partially explained by phagocytosis
  212. Comparison between three not pharmacological strategies aimed to prevent the dissemination of the A/H1N1 influenza virus in Colombia
  213. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  214. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
  215. Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina:reporte de dos casos en Colombia
  216. Xantelasma gástrico sobre pólipo hiperplásico
  217. Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America
  218. Transmisión de enfermedades en los vuelos comerciales: del mito a la realidad
  219. Comprometidos con el conocimiento y el control de las infecciones
  220. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
  221. Validación de Índices Pronósticos e Infección del Sitio Quirúrgico en Hospitales de Colombia
  222. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008
  223. Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment
  224. Third-Line Agent Selection for Patients with Type 2 Diabetes Mellitus Uncontrolled with Sulfonylureas and Metformin
  225. Haga usted el diagnóstico. Primera parte
  226. Haga usted el diagnóstico. Segunda parte
  227. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
  228. Malaria in a Liver Transplant Recipient: A Case Report
  229. Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries
  230. Extra Length of Stay of Nosocomial Infections in Pediatric ICUs of Colombia and Mexico. Findings of the International Nosocomial Infection Control Consortium (INICC)
  231. Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003
  232. Canales Endémicos y Marcadores de Resistencia Bacteriana, en Instituciones de Tercer nivel de Bogota, Colombia
  233. Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals: Findings of the International Nosocomial Infection Control Consortium
  234. Community-associated Methicillin-resistantStaphylococcus aureus, Colombia
  235. AIDS in the Intensive Care Unit
  236. Application of natural gamma radiometric equipment in an underground mine in Spain
  237. Comparación de dos pruebas de aglutinación (Toxolatex ® y Toxoscreen ®) en el diagnóstico de la toxoplasmosis: propuesta de inclusión en un programa de control
  238. Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population
  239. Lagochilascaris minor IN A PATIENT FROM THE COLOMBIAN AMAZON: A CASE REPORT
  240. Current status of onchocerciasis in Colombia.
  241. Dissemination Control of the Antimicrobial Resistance in the Intensive Care Unit